Active substance
Estrogens conjugated equine
- SFDA 6
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| PREMARIN 0.625MG TAB | 0.625 mg | Tablet · Oral use | 100 Blister | SAR 27.45 | Generic · Prescription | WYETH | Withdrawn by MAH · Not Marketed |
| PREMARIN TAB. 1.25 MG. | 1.25 mg | Tablet · Oral use | 20 Blister | SAR 10.65 | NCE · Prescription | WYETH | Withdrawn by MAH · Not Marketed |
| PREMARIN TAB. 1.25 MG. | 1.25 mg | Tablet · Oral use | 100 Blister | SAR 36.20 | Generic · Prescription | WYETH | Withdrawn by MAH · Not Marketed |
| PREMARIN VAG CREAM 0.625MG | 0.0625 % | Cream · Vaginal use | 1 Tube | SAR 15.70 | NCE · Prescription | WYETH | Withdrawn by MAH · Not Marketed |
| PREMPAK -C 0.625MG TAB | 0.625 mg | Tablet · Oral use | 40 Blister | SAR 26.85 | Generic · Prescription | WYETH | Withdrawn by MAH · Not Marketed |
| PREMPAK C 1.25MG TABS | 1.25 mg | Tablet · Oral use | 40 Blister | SAR 31.90 | Generic · Prescription | WYETH | Withdrawn by MAH · Not Marketed |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.